AIZANT DRUG RESEARCH SOLUTIONS PVT LTD

Company Profile:

AIZANT DRUG RESEARCH SOLUTIONS PVT LTD is a prominent Contract Research Organization (CRO) and Contract research and Manufacturing Organization (CDMO) based in Hyderabad, India. Established in 2005, the company provides thorough research, research, and manufacturing services to the medical, biotechnology, and generic industries worldwide. Aizant is recognized to its expertise in various stages of drug research, from early-phase research to commercial manufacturing support. And Factory or Trader:

AIZANT DRUG RESEARCH SOLUTIONS PVT LTD operates primarily as a Contract research and Manufacturing Organization (CDMO). This means they possess signifiis able tot manufacturing capabilities and facilities where they develop and create medical items and formulations under contract to their clients. Therefore, they're a manufacturing and research service provider, akin to a factory that produces goods to other companies, rather than a trading company that buys and sells finished items. Based on my observations, they're not a trader. Specifically Key Services:

The company'service portfolio includes:

Bioequivalence and Bioavailability Studies

Clinical Research (Phase I to Phase IV)

Pharmacokinetics and Biostatistics

Clinical Data regulation

Analytical Research and research

Formulation research

Small-scale to commercial-scale manufacturing to medical items. In my experience, Aizant is dedicated to delivering high-condition, regulatory-compliant solutions, assisting their clients through the complex journey of drug research and market entry.

Here are some of the product categories associated with AIZANT DRUG RESEARCH SOLUTIONS PVT LTD (based on publicly available information, which may not be exhaustive):

* Pharmaceutical Formulations

* Active Pharmaceutical Ingredients (APIs)

* Generics

* Finished Dosage Forms

Please note that the specific products within these categories may vary and are subject to change. For the most up-to-date product list, it is best to consult the company directly.